Chapter category: Parasitic Disease

Purine and Pyrimidine Metabolism in Leishmania

This chapter appears in the following book:

Drug Targets in Kinetoplastid Parasites

Edited by: Hemanta K. Majumder
ISBN: 978-0-387-77569-2
» Get more information about this book at landesbioscience.com «

Chapter authors:
Nicola S. Carter, Phillip Yates, Cassandra S. Arendt, Jan M. Boitz and Buddy Ullman

[+] view image

Purines and pyrimidines are indispensable to all life, performing many vital functions for cells: ATP serves as the universal currency of cellular energy, cAMP and cGMP are key second messenger molecules, purine and pyrimidine nucleotides are precursors for activated forms of both carbohydrates and lipids, nucleotide derivatives of vitamins are essential cofactors in metabolic processes, and nucleoside triphosphates are the immediate precursors for DNA and RNA synthesis. Unlike their mammalian and insect hosts, Leishmania lack the metabolic machinery to make purine nucleotides de novo and must rely on their host for preformed purines. The obligatory nature of purine salvage offers, therefore, a plethora of potential targets for drug targeting, and the pathway has consequently been the focus of considerable scientific investigation. In contrast, Leishmania are prototrophic for pyrimidines and also express a small complement of pyrimidine salvage enzymes. Because the pyrimidine nucleotide biosynthetic pathways of Leishmania and humans are similar, pyrimidine metabolism in Leishmania has generally been considered less amenable to therapeutic manipulation than the purine salvage pathway. However, evidence garnered from a variety of parasitic protozoa suggests that the selective inhibition of pyrimidine biosynthetic enzymes offers a rational therapeutic paradigm. In this chapter, we present an overview of the purine and pyrimidine pathways in Leishmania, make comparisons to the equivalent pathways in their mammalian host, and explore how these pathways might be amenable to selective therapeutic targeting.

Nicola S. Carter
Department of Biochemistry and Molecular Biology, Oregon Health & Science University

Phillip Yates
Department of Biochemistry and Molecular Biology, Oregon Health & Science University

Cassandra S. Arendt
Department of Biochemistry and Molecular Biology, Oregon Health & Science University

Jan M. Boitz
Department of Biochemistry and Molecular Biology, Oregon Health & Science University

Buddy Ullman
Department of Biochemistry and Molecular Biology, Oregon Health & Science University

» Access chapter for $19

Additional chapters from this book:

Selective Lead Compounds Against Kinetoplastid Tubulin

R.E. Morgan and K.A. Werbovetz

Kinetoplastid parasites are responsible for the potentially fatal diseases leishmaniasis, African sleeping sickness and Chagas disease. The current treatments for these diseases are far from ideal and...

Unique Characteristics of the Kinetoplast DNA Replication Machinery Provide Potential Drug Targets in Trypanosomatids

Dotan Sela, Neta Milman, Irit Kapeller, Aviad Zick, Rachel Bezalel, Nurit Yaffe and Joseph Shlomai

Kinetoplast DNA (kDNA) is a remarkable DNA structure found in the single mitochondrion of flagellated protozoa of the order Kinetoplastida. In various parasitic species of the family Trypanosomatidae,...

Arsenite Resistance in Leishmania and Possible Drug Targets

Gaganmeet Singh, K.G. Jayanarayan and Chinmoy Sankar Dey

Parasitic infections are of enormous public health importance. Leishmaniasis is currently regarded as the second-most dreaded parasitic disease after malaria (WHO). Visceral leishmaniasis or kala-azar...

Antiparasitic Chemotherapy: Tinkering with the Purine Salvage Pathway

Alok Kumar Datta, Rupak Datta and Banibrata Sen

Distinguishable differences between infecting organisms and their respective hosts with respect to metabolism and macromolecular structure provide scopes for detailed characterization of target protei...

Histone Deacetylases

David Horn

Deacetylation of histones is required for gene regulation and cell cycle progression and the mediators, the histone deacetylases, are being vigorously pursued as drug targets for cancer chemotherapy. ...

Fishing for Anti-Leishmania Drugs: Principles and Problems

Emanuela Handman, Lukasz Kedzierski, Alessandro D. Uboldi and James W. Goding

To date, there are no vaccines against any of the major parasitic diseases including leishmaniasis, and chemotherapy is the main weapon in our arsenal. Current drugs are toxic and expensive, and are l...

Drugs and Transporters in Kinetoplastid Protozoa

Scott M. Landfear

Kinetoplastid protozoa express hundreds of membrane transport proteins that allow them to take up nutrients, establish ion gradients, efflux metabolites, translocate compounds from one intracellular c...

DNA Topoisomerases of Leishmania: The Potential Targets for Anti-Leishmanial Therapy

Benu Brata Das, Agneyo Ganguly and Hemanta K. Majumder

Protozoan parasites of the genus Leishmania cause severe diseases that threaten human beings, both for the high mortality rates involved and the economic loss resulting from morbidity, primarily in th...

Searching the Tritryp Genomes for Drug Targets

Peter J. Myler

The recent publication of the complete genome sequences of Leishmania major, Trypanosoma brucei and Trypanosoma cruzi revealed that each genome contains 8300-12,000 protein-coding genes, of which ~650...

Purine and Pyrimidine Metabolism in Leishmania

Nicola S. Carter, Phillip Yates, Cassandra S. Arendt, Jan M. Boitz and Buddy Ullman

Sterol 14-Demethylase Inhibitors for Trypanosoma cruzi Infections

Frederick S. Buckner

Chagas disease is caused by infection with the protozoan pathogen, Trypanosoma cruzi. The only approved therapeutics for treating Chagas disease are two nitroheterocyclic compounds (benznidazole and n...

Targeting Glycoproteins or Glycolipids and Their Metabolic Pathways for Anti-Parasite Therapy

Sumi Mukhopadhyay nee Bandyopadhyay and Chitra Mandal

Carbohydrate-based therapy, known as glycotherapeutics, is a new and emerging field that promises to be the future hope for combating kinetoplastid infections more efficiently and effectively. Targeti...

Chapter category: Parasitic Disease

Purine and Pyrimidine Metabolism in Leishmania

Additional chapters from this book:

SIGN IN